Further immune analysis discovered that the BIRC5 mRNA expression was associated with the presence of immune cells in the tumor and the expression of immune checkpoint genes, indicating that BIRC5 may influence the immunological condition of PCa patients. The gene discussed is BIRC5; the disease is neoplasm.